Product Categories
| Country: | China |
|---|---|
| Tel: | 0531-0531-68652053 |
| Mobile: | 15863796298 |
| E-mail: | 2310993908@qq.com |
| QQ: | 3007997694 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide | C16H14N2O3S | Details |
| C10H11F3N2O5 | Details |
| Details |
| Details |
| C17H27NO2 | Details |
| Details |
| BendaMustine IMpurity | Details |
| 7-DesMethylagoMelatine | C14H15NO2 | 152302-45-9 | Details |
| EsoMeprazole iMpurity | C11H15NO3 | Details |
| Blonanserin iMpurity | C23H30FN3 | Details |
| acotiaMide iMpurity | C13H12N2O6S | Details |
| AXITINIB | C22H18N4OS | 319460-85-0 | Details |
| Edoxaban iMpurities | C14H27N3O3 | Details |
| Azilsartan impurity | C25H23N3O4 | 147404-76-0 | Details |
| R-DULOXETINE HYDROCHLORIDE | C18H20ClNOS | 910138-96-4 | Details |
| C18H29N6O11P | Details |
| Linagliptin iMpurity | C25H28N8O2 | Details |
| Ritonavir IMpurity | C32H42N4O8S | Details |
| Etoricoxib IMpurity | C18H16N2O2S | Details |
| Gefitinib iMpurity | C22H23ClFN3O4 | Details |
| Isradipine IMpurity | Details |
| 2-Bromo-2-(2-fluorophenyl)-1-cyclopropylethanone | C11H10BrFO | 204205-33-4 | Details |
| Istradefylline iMpurity | Details |
| Posaconazole Impurity 27 | C37H42F2N8O4 | 1229428-89-0 | Details |
| Rivaroxaban iMpurity | C15H17N3O5 | Details |
| Lurasidon hydrochloride iMpurity | C19H28N4S | Details |
| ofacitinib iMpurity | C14H20N6O | Details |
| Details |
| ethyl 4-hydroxy-2-oxopyrrolidine-1-acetate | C8H13NO4 | 62613-81-4 | Details |
| IMatinib iMpurity | C24H21N5O | Details |
| 7-[(2-Aminopropyl)amino]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid | C17H20FN3O4 | 172426-87-8 | Details |
| Adapalene iMpurity | Details |
| Aceclofenac | C16H13Cl2NO4 | 89796-99-6 | Details |
| 2-[4-(2-Methylpropyl)phenyl] ethanol | C24H32O | Details |
| RofluMilast related substance | C17H14Cl2F2N2O3 | 162401-43-6 | Details |
| 6a,9a-Difluoro-11b,17a-dihydroxy-16a-Methyl-3-oxoandrosta-1,4-diene-17b-carboxylic Acid | C21H26F2O5 | Details |
| Vortioxetine iMpurity | C10H14BrClN2 | Details |
| 2-Hydroxybenzimidazole | C7H6N2O | 615-16-7 | Details |
| (2S)-1-[(2S)-2-Methyl-3-Methylsulfinylpropanoyl]pyrrolidine-2-carboxylic acid | C14H22N2O6S2 | Details |
| 3-Methyl- N-[4-trifluo- roMethyl) phenyl]-4- isoxazole carboxaMide | Details |
| 4-(4-aMino-3-chlorophenoxy)-7-Methoxyquinoline-6-carboxaMide | C17H14ClN3O3 | 417722-93-1 | Details |
| 4,8-Dichloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-β]pyridin-11-one (Loratadine Impurity) | C14H9Cl2NO | 133330-60-6 | Details |
| 3-[4-(2-Methoxyethyl)phenoxy]- | C12H18O4 | 62572-90-1 | Details |
| (1R,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester | C20H18N2O4 | 171596-44-4 | Details |
| Vildagliptin iMpurity A-F | C7H10N2O3 | Details |
| (2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETAMIDE | C15H21N3O4S | Details |
| (2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyriMidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol) | Details |
| 4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid | C13H14N2O6S | 1357477-99-6 | Details |
| Albendazole iMpurity | Details |
| 4-(4-aMino-3-chlorophenoxy)-7-Methoxyquinoline-6-carboxaMide | C12H13ClN2O | Details |
| 1-((2'-cyanobiphenyl-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid | C26H23N3O2 | 1098100-87-8 | Details |
| ALLOPURINOL IMPURITY A | C5H4N4O | Details |
| 3-(4-HYDROXY-3-IODOBENZOYL)-2-BUTYLBENZOFURAN | C19H17IO3 | 147030-50-0 | Details |
| Ticagrelor iMpurity | C27H45N5O8S | Details |
| 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole | C33H25BrN4 | 124750-51-2 | Details |
| 3-Oxo-4-aza-5-alpha-androstane-17-beta-carboxylic acid | C19H29NO3 | 103335-55-3 | Details |
| 9-[(2-Acetoxyethoxy)methyl]-N2-acetylguanine | C12H15N5O5 | 75128-73-3 | Details |
| 2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil | C33H34N6O6 | 1185255-99-5 | Details |
| 5,10-Dihydro-2-methyl- | C12H10N2S2 | 612507-13-8 | Details |
| 1-[2-[4-Hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]-α,α-diphenyl | C28H32N2O3 | 215032-24-9 | Details |
| 2-[4-[[(2RS)-Oxiran-2-yl]Methoxy]phenyl]acetaMide | C11H13NO3 | Details |
| BUMETANIDE RELATED COMPOUND A (25 MG) (3- AMINO-4-PHENOXY-5-SULFAMOYLBENZOIC ACID) | Details |
| Fulvestrant | C32H47F5O3S | 129453-61-8 | Details |
| Cefalexin IMpurity ( 3-aMinoMethylene-6-phenylpiperazine-2,5-dione) | C11H11N3O2 | 65870-51-1 | Details |
| LevetiracetaM IMurity (L-2-AMinobutanaMide HCl,S-2-AMinobutanaMide HCl) | C8H14N2O3 | Details |
| Cefaclor EP IMpurity | Details |
| Buspirone | C21H31N5O2 | 36505-84-7 | Details |
| ALMOTRIPTAN | C21H31N3O7S | 181183-52-8 | Details |
| Gabapentin Related Compound E | C9H14O4 | 67950-95-2 | Details |
| Lisinopril iMpurity | C21H31N3O5 | Details |
| Cetirizine IMpurity (4-Chlorobenzophenone | C21H25ClN2O3 | Details |
| Erlotinib | C13H17NO7 | Details |
| Bisoprolol IMpurity | C18H31NO4 | Details |
| Bosentan | C27H29N5O6S | 147536-97-8 | Details |
| BENZOOXAZOL-2-YLAMINE | C7H6N2O | 4570-41-6 | Details |
| Deferasirox iMpurity | C42H28N6O8S | Details |
| C16H16ClNO3S | Details |
| CitalopraM IMpurity | Details |
| Eprosartan IMpurity | Details |
| Febuxostat | C16H16N2O3S | 144060-53-7 | Details |
| Cinacalcet IMpurity | C22H26F3N | 1229224-93-4 | Details |
| Aripiprazole iMpurity | C13H13D2NO3 | 1008531-47-2 | Details |
| CYCLOBENZAPRINE HCL | C20H22ClN | 6202-23-9 | Details |
| AMbroxol CycloiMine IMpurity | C16H22Br2N2O3 | Details |
| Aminopterin | C19H20N8O5 | 54-62-6 | Details |
| AnhydrosiMvastatin | Details |
| AMlodipine iMpurity | C26H31ClN2O8S | Details |
| GLIPIZIDE IMPURITY | C15H24ClN3O3S | Details |
| Bicalutamide | C18H14F4N2O4S | 90357-06-5 | Details |
| Aprepitant | C23H21F7N4O3 | 170729-80-3 | Details |
| DesvancosaMinyl VancoMycin | C59H62Cl2N8O22 | 101485-50-1 | Details |
| fenofibrate iMpurity | Details |
| IMp. A (EP): (RS)-9,10-Difluoro-3-Methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid (FPA | Details |
| EzetiMibe iMpurity (tetrahydro-pyran-2-one | Details |
| EnzalutaMide IMpurity | C17H8F6N4S | Details |
| Enrofloxacin | C19H22FN3O3 | 93106-60-6 | Details |
| IMp. A (EP): Pyrazine-2-carboxylic Acid | Details |
| Irinotecan Hydroxyl Acid | C22H22N2O6 | 142677-15-4 | Details |
| Ketorolac TroMetaMol IMp. I (EP) | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 | ||||